Pharmaceutical

Ose Immunotherapeutics : Documents made available to the shareholders for the combined general meeting of June 25th, 2025

Documents made available to the shareholders for the combined general meeting of June 25th, 2025 Nantes, June 4th, 2025, 8…

7 months ago

Roche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)

Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA Evrysdi offers…

7 months ago

World’s Leading Institutions and IBA launch Proton Therapy Academy to shape the future of cancer care

New global education initiative unveiled at 2025 PTCOG Annual Conference Louvain-la-Neuve, Belgium, 4 June 2025 - IBA (Ion Beam Applications…

7 months ago

Historic $40 Million Gift to CU Anschutz Dept. of Ophthalmology will Fuel Research and New Therapies

The anonymous gift to Colorado's only academic eye center will boost research into treating and curing the most serious eye…

7 months ago

ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis

TOKYO, June 3, 2025 /PRNewswire/ -- ThinkCyte, a life science company pioneering advanced AI-powered cell analysis and sorting technologies, today…

7 months ago

Digital Pathology Market worth US$2.75 billion by 2030 with 13.5% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., June 3, 2025 /PRNewswire/ -- The global Digital Pathology Market, valued at US$1.29 billion in 2024 stood at US$1.46…

7 months ago

MNML Aesthetics Integrates ShapeScale: Introducing Revolutionary 3D Body Analysis to the MNML Tone Method

Enhanced Body Contouring Protocol Combines Advanced 3D Body Imaging with Multi-Modality Treatments for Unparalleled Results RICHARDSON, Texas, June 3, 2025…

7 months ago

3 Boomerang Capital Forms LSOMS Holdings, L.P., a Quality & Regulatory Consulting Platform Led by Life Sciences Veteran John Duffin

GREENWICH, Conn. and FISHERS, Ind., June 3, 2025 /PRNewswire/ -- 3 Boomerang Capital, LP ("3BC"), a healthcare-focused, lower-middle-market private equity firm,…

7 months ago

Antheia Raises $56 Million in Series C Financing to Fuel Global Commercialization Strategy

New funding will support the company's rapid growth trajectory and efforts to transform pharmaceutical supply chains with its advanced biomanufacturing platform…

7 months ago

Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a…

7 months ago